Inventor · disambiguated record
Konrad Honold
Also filed as: HONOLD KONRAD
24 granted patents·5 pending applications·280 citations·filing 1996–2014
95Inventor score
Files withHOFFMANN LA ROCHE12ROCHE DIAGNOSTICS GMBH9HONOLD KONRAD3ANGELIKA ESSWEIN WOLFGANG SCHA1BOEHRINGER MANNHEIM GMBH1
Top patents by PatentIndex Score
29 records- 0195US6391633B1Production of erythropoietin by endogenous gene activationROCHE DIAGNOSTICS GMBH·Filed 1998·Granted May 21, 2002·158 cites·22 claims
- 0286US6544748B2Preparation of erythropoietin by endogenous gene activationROCHE DIAGNOSTICS GMBH·Filed 2001·Granted Apr 8, 2003·10 cites·33 claims
- 0385US8067599B2Imidazo [4,5-B] pyridine and pyrrolo [2,3-B] pyridine protein kinase inhibitorsHONOLD KONRAD·Filed 2007·Granted Nov 29, 2011·11 cites·9 claims
- 0484US7214532B2Methods for identifying human cell lines useful for endogenous gene activation, isolated human cell lines identified thereby, and uses thereofROCHE DIAGNOSTICS GMBH·Filed 2003·Granted May 8, 2007·9 cites·5 claims
- 0583US7655651B2Amide derivatives of 3-phenyl-dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2005·Granted Feb 2, 2010·9 cites·8 claims
- 0683US7494993B2Amide derivatives of 7-amino-3-phenyl-dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2005·Granted Feb 24, 2009·8 cites·15 claims
- 0777US7786113B2Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2005·Granted Aug 31, 2010·3 cites·9 claims
- 0877US7618964B2Benzamide derivatives, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2005·Granted Nov 17, 2009·3 cites·11 claims
- 0977US6555373B1Methods for identifying human cell lines useful for endogenous gene activation isolated human cell lines identified thereby, and uses thereofROCHE DIAGNOSTICS GMBH·Filed 2000·Granted Apr 29, 2003·4 cites·7 claims
- 1075US8058283B27H-pyrido[3,4-D]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitorsHONOLD KONRAD·Filed 2007·Granted Nov 15, 2011·4 cites·6 claims
- 1173US7550589B26-(2-alkyl-phenyl)-pyrido[2,3-D]pyrimidines useful as protein kinase inhibitorsHOFFMANN LA ROCHE·Filed 2005·Granted Jun 23, 2009·1 cites·2 claims
- 1272US7091345B2Amino-substituted dihydropyrimido[4,5-D]pyrimidinone derivativesHOFFMANN LA ROCHE·Filed 2003·Granted Aug 15, 2006·9 cites·39 claims
- 1371US7776878B2Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2006·Granted Aug 17, 2010·1 cites·6 claims
- 1471US7189732B2Pyrido[2,3-d]pyrimidine dichloro-phenyl derivativesHOFFMANN LA ROCHE·Filed 2005·Granted Mar 13, 2007·1 cites·16 claims
- 1571US7186529B2Preparation of erythropoietin by endogenous gene activationROCHE DIAGNOSTICS GMBH·Filed 2003·Granted Mar 6, 2007·2 cites·26 claims
- 1665US7163941B2Pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2004·Granted Jan 16, 2007·2 cites·41 claims
- 1761US7169781B2Imidazole derivatives and their use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2004·Granted Jan 30, 2007·1 cites·12 claims
- 1861US6673816B1Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disordersESSWEIN ANGELIKA·Filed 1999·Granted Jan 6, 2004·9 cites·3 claims
- 1959US6284541B1Positive-negative selection for homologous recombinationROCHE DIAGNOSTICS GMBH·Filed 1998·Granted Sep 4, 2001·12 cites·32 claims
- 2058US2009247518A16-(2-alkyl-phenyl)-pyrido[2,3-d]pyrimidines useful as protein kinase inhibitorsHONOLD KONRAD·Filed 2009·Application pending·0 cites
- 2154US7008764B1Optimization of cells for endogenous gene activationROCHE DIAGNOSTICS GMBH·Filed 1998·Granted Mar 7, 2006·13 cites·24 claims
- 2254US6548296B1Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereofROCHE DIAGNOSTICS GMBH·Filed 1998·Granted Apr 15, 2003·6 cites·15 claims
- 2354US2002177195A1Production of human mutated proteins in human cells by means of homologous recombinationFiled 2002·Application pending·0 cites
- 2453US7393936B2Method for the recombinant production and purification of protein kinasesHOFFMANN LA ROCHE·Filed 2004·Granted Jul 1, 2008·0 cites·12 claims
- 2552US2015044232A1Markers for the responsiveness to anti-cd44 antibodiesHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2646US2003032813A1Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disordersANGELIKA ESSWEIN WOLFGANG SCHA·Filed 2002·Application pending·0 cites
- 2742US2009227578A1Azabenzimidazole Derivatives, Their Manufacture and Use as Anti-Cancer AgentsENGH RICHARD·Filed 2006·Application pending·0 cites
- 2840US5888967AUse of plasminogen activators to stimulate local bone growthBOEHRINGER MANNHEIM GMBH·Filed 1996·Granted Mar 30, 1999·4 cites·7 claims
- 2932US6444441B1Production of human mutated proteins in human cells by means of homologous recombinationROCHE DIAGNOSTICS GMBH·Filed 1998·Granted Sep 3, 2002·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Konrad Honold files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →